Literature DB >> 18809581

The p85alpha subunit of class IA phosphatidylinositol 3-kinase regulates the expression of multiple genes involved in osteoclast maturation and migration.

Veerendra Munugalavadla1, Sasidhar Vemula, Emily Catherine Sims, Subha Krishnan, Shi Chen, Jincheng Yan, Huijie Li, Paul J Niziolek, Clifford Takemoto, Alexander G Robling, Feng-Chun Yang, Reuben Kapur.   

Abstract

Intracellular signals involved in the maturation and function of osteoclasts are poorly understood. Here, we demonstrate that osteoclasts express multiple regulatory subunits of class I(A) phosphatidylinositol 3-kinase (PI3-K) although the expression of the full-length form of p85alpha is most abundant. In vivo, deficiency of p85alpha results in a significantly greater number of trabeculae and significantly lower spacing between trabeculae as well as increased bone mass in both males and females compared to their sex-matched wild-type controls. Consistently, p85alpha(-/-) osteoclast progenitors show impaired growth and differentiation, which is associated with reduced activation of Akt and mitogen-activated protein kinase extracellular signal-regulated kinase 1 (Erk1)/Erk2 in vitro. Furthermore, a significant reduction in the ability of p85alpha(-/-) osteoclasts to adhere to as well as to migrate via integrin alphavbeta3 was observed, which was associated with reduced bone resorption. Microarray as well as quantitative real-time PCR analysis of p85alpha(-/-) osteoclasts revealed a significant reduction in the expression of several genes associated with the maturation and migration of osteoclasts, including microphathalmia-associated transcription factor, tartrate-resistant acid phosphatase, cathepsin K, and beta3 integrin. Restoring the expression of the full-length form of p85alpha but not the version with a deletion of the Src homology-3 domain restored the maturation of p85alpha(-/-) osteoclasts to wild-type levels. These results highlight the importance of the full-length version of the p85alpha subunit of class I(A) PI3-K in controlling multiple aspects of osteoclast functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809581      PMCID: PMC2593377          DOI: 10.1128/MCB.00920-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

1.  Multiple isoforms of the regulatory subunit for phosphatidylinositol 3-kinase (PI3-kinase) are expressed in neurons in the rat brain.

Authors:  B C Shin; M Suzuki; K Inukai; M Anai; T Asano; K Takata
Journal:  Biochem Biophys Res Commun       Date:  1998-05-19       Impact factor: 3.575

2.  Wortmannin inhibits spreading and chemotaxis of rat osteoclasts in vitro.

Authors:  M F Pilkington; S M Sims; S J Dixon
Journal:  J Bone Miner Res       Date:  1998-04       Impact factor: 6.741

3.  Role of 1 alpha,25-dihydroxyvitamin D3 in osteoclast differentiation and function.

Authors:  T Suda; E Jimi; I Nakamura; N Takahashi
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

4.  Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Authors:  D L Lacey; E Timms; H L Tan; M J Kelley; C R Dunstan; T Burgess; R Elliott; A Colombero; G Elliott; S Scully; H Hsu; J Sullivan; N Hawkins; E Davy; C Capparelli; A Eli; Y X Qian; S Kaufman; I Sarosi; V Shalhoub; G Senaldi; J Guo; J Delaney; W J Boyle
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

5.  Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.

Authors:  Y Abu-Amer; F P Ross; J Edwards; S L Teitelbaum
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

6.  Osteopetrosis in mice lacking haematopoietic transcription factor PU.1.

Authors:  M M Tondravi; S R McKercher; K Anderson; J M Erdmann; M Quiroz; R Maki; S L Teitelbaum
Journal:  Nature       Date:  1997-03-06       Impact factor: 49.962

7.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

Authors:  H Yasuda; N Shima; N Nakagawa; K Yamaguchi; M Kinosaki; S Mochizuki; A Tomoyasu; K Yano; M Goto; A Murakami; E Tsuda; T Morinaga; K Higashio; N Udagawa; N Takahashi; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

8.  Identification of two SH3-binding motifs in the regulatory subunit of phosphatidylinositol 3-kinase.

Authors:  R Kapeller; K V Prasad; O Janssen; W Hou; B S Schaffhausen; C E Rudd; L C Cantley
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

9.  Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase.

Authors:  H Suzuki; Y Terauchi; M Fujiwara; S Aizawa; Y Yazaki; T Kadowaki; S Koyasu
Journal:  Science       Date:  1999-01-15       Impact factor: 47.728

10.  RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.

Authors:  N Nakagawa; M Kinosaki; K Yamaguchi; N Shima; H Yasuda; K Yano; T Morinaga; K Higashio
Journal:  Biochem Biophys Res Commun       Date:  1998-12-18       Impact factor: 3.575

View more
  17 in total

1.  Insulin-like growth factor-binding protein-2 is required for osteoclast differentiation.

Authors:  Victoria E DeMambro; Laura Maile; Christine Wai; Masanobu Kawai; Teresa Cascella; Clifford J Rosen; David Clemmons
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741

2.  3BP2 adapter protein is required for receptor activator of NFκB ligand (RANKL)-induced osteoclast differentiation of RAW264.7 cells.

Authors:  Amel GuezGuez; Virginie Prod'homme; Xavier Mouska; Alice Baudot; Claudine Blin-Wakkach; Robert Rottapel; Marcel Deckert
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

Review 3.  Molecular genetic studies of gene identification for osteoporosis: the 2009 update.

Authors:  Xiang-Hong Xu; Shan-Shan Dong; Yan Guo; Tie-Lin Yang; Shu-Feng Lei; Christopher J Papasian; Ming Zhao; Hong-Wen Deng
Journal:  Endocr Rev       Date:  2010-03-31       Impact factor: 19.871

4.  Important roles of PI3Kgamma in osteoclastogenesis and bone homeostasis.

Authors:  Heeseog Kang; Woochul Chang; Marja Hurley; Agnès Vignery; Dianqing Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-02       Impact factor: 11.205

5.  Balanced interactions between Lyn, the p85alpha regulatory subunit of class I(A) phosphatidylinositol-3-kinase, and SHIP are essential for mast cell growth and maturation.

Authors:  Peilin Ma; Sasidhar Vemula; Veerendra Munugalavadla; Jinbiao Chen; Emily Sims; Jovencio Borneo; Takako Kondo; Baskar Ramdas; Raghuveer Singh Mali; Shuo Li; Eri Hashino; Clifford Takemoto; Reuben Kapur
Journal:  Mol Cell Biol       Date:  2011-07-26       Impact factor: 4.272

6.  The PI3K pathway drives the maturation of mast cells via microphthalmia transcription factor.

Authors:  Peilin Ma; Raghuveer Singh Mali; Veerendra Munugalavadla; Subha Krishnan; Baskar Ramdas; Emily Sims; Holly Martin; Joydeep Ghosh; Shuo Li; Rebecca J Chan; Gerald Krystal; Andrew W Craig; Clifford Takemoto; Reuben Kapur
Journal:  Blood       Date:  2011-07-25       Impact factor: 22.113

7.  The loss of Cbl-phosphatidylinositol 3-kinase interaction perturbs RANKL-mediated signaling, inhibiting bone resorption and promoting osteoclast survival.

Authors:  Naga Suresh Adapala; Mary F Barbe; Wallace Y Langdon; Mary C Nakamura; Alexander Y Tsygankov; Archana Sanjay
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

8.  Inhibitory effects of ZSTK474, a novel phosphoinositide 3-kinase inhibitor, on osteoclasts and collagen-induced arthritis in mice.

Authors:  Shoko Toyama; Naoto Tamura; Kazuhiko Haruta; Takeo Karakida; Shigeyuki Mori; Tetsuo Watanabe; Takao Yamori; Yoshinari Takasaki
Journal:  Arthritis Res Ther       Date:  2010-05-18       Impact factor: 5.156

9.  Loss of Cbl-PI3K interaction enhances osteoclast survival due to p21-Ras mediated PI3K activation independent of Cbl-b.

Authors:  Naga Suresh Adapala; Mary F Barbe; Alexander Y Tsygankov; Joseph A Lorenzo; Archana Sanjay
Journal:  J Cell Biochem       Date:  2014-07       Impact factor: 4.429

10.  Adult-Onset Deletion of β-Catenin in (10kb)Dmp1-Expressing Cells Prevents Intermittent PTH-Induced Bone Gain.

Authors:  Rajendra Kedlaya; Kyung Shin Kang; Jung Min Hong; Vidya Bettagere; Kyung-Eun Lim; Daniel Horan; Paola Divieti-Pajevic; Alexander G Robling
Journal:  Endocrinology       Date:  2016-06-02       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.